Ahmad Mehravaran
Overview
Explore the profile of Ahmad Mehravaran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mirahmadi H, Mehravaran A, Kavand M, Salimi Khorashad A, Rezaee N
Iran J Basic Med Sci
. 2025 Feb;
28(3):347-354.
PMID: 39906621
Objectives: An ideal strategy to control acute or chronic toxoplasmosis can be the development and production of an effective vaccine. Liposomes as immunoadjuvants may be utilized to boost immune reactions...
2.
Mirahmadi H, Shahrakipour A, Mehravaran A, Rahmati-Balaghaleh M, Zarean M, Etemadi S, et al.
Am J Trop Med Hyg
. 2022 Jan;
106(3):841-845.
PMID: 35100562
Malaria is one of the most serious health problems in many countries, including Iran. Accurate diagnosis is important regardless of the elimination status of a country. A cross-sectional study was...
3.
Mirahmadi H, Ghaderi A, Barani S, Alijani E, Mehravaran A, Shafiei R
Vet Med Sci
. 2021 Nov;
8(1):343-348.
PMID: 34800356
Babesiosis is a globally distributed zoonotic parasitic disease in a broad range of vertebrates with great importance in the veterinary field. The standard diagnostic test for Babesiosis in animals is...
4.
Mirahmadi H, Kazemipour N, Yazdiani A, Mehravaran A, Basseri H, Mohammadi L, et al.
Ethiop J Health Sci
. 2021 Oct;
31(4):743-752.
PMID: 34703173
Background: Malaria is one of the main parasitic diseases and a major health issue in some countries. This study aims to determine the rate and type of infections of Anopheles...
5.
Asadi P, Mehravaran A, Soltanloo N, Abastabar M, Akhtari J
Curr Med Mycol
. 2021 Sep;
7(1):71-78.
PMID: 34553102
Cutaneous fungal infections are the fourth most common health problem, which involves approximately one billion people worldwide. Drug delivery to the skin seems to be the best choice for superficial...
6.
Mirahmadi H, Safari T, Metanat M, Tabatabaei S, Mehravaran A, Raeghi S
Ethiop J Health Sci
. 2021 Apr;
30(4):513-520.
PMID: 33897211
Background: Apical Membrane antigen 1 (AMA-1) is an important membrane protein that presents in all Plasmodium species and participates in critical phases in the attraction of cells. In human, it...
7.
Mirahmadi H, Nia M, Ebrahimzadeh A, Mehravaran A, Shafiei R, Rahimi M, et al.
J Water Health
. 2019 Oct;
17(5):717-727.
PMID: 31638023
This study aimed to detect the presence of Acanthamoeba spp. in different water resources of Zahedan, southeast of Iran, and also systematically reviewed all publications regarding Acanthamoeba in Iran (2005-2018)....
8.
Mehravaran A, Rezaei Nasab M, Mirahmadi H, Sharifi I, Alijani E, Nikpoor A, et al.
Iran J Basic Med Sci
. 2019 Oct;
22(8):922-931.
PMID: 31579449
Objectives: Protection against leishmaniasis, in the murine model, is dependent on developing a potent CD4 mediated Th1 type response. Liposomes can be applied as immunoadjuvants to stimulate immune responses to...
9.
Osanloo M, Assadpour S, Mehravaran A, Abastabar M, Akhtari J
Curr Med Mycol
. 2019 Mar;
4(4):31-36.
PMID: 30815615
Skin is an important organ of the body due to offering an accessible and convenient site for drug administration. One of the disadvantages of transdermal drug delivery is the low...
10.
Mehravaran A, Rezaei Nasab M, Mirahmadi H, Sharifi I, Alijani E, Nikpoor A, et al.
Infect Genet Evol
. 2019 Feb;
70:27-35.
PMID: 30738195
There is a need for new, effective, and less expensive and toxic treatment for Leishmaniasis. It seems that the use of a suitable adjuvant and a delivery system is effective...